Precision testing for healthier joints.
Rheumatoid arthritis (RA) affects over 1.3 million Americans and 14 million people globally, with numbers rising. This chronic autoimmune disease causes debilitating pain, joint damage, and reduced quality of life, impacting both patients and caregivers. Effective treatment requires precise, ongoing monitoring to adjust therapies and prevent disease progression, yet current RA management often relies on subjective assessments, leading to delayed or suboptimal care.
Many RA patients lack access to quantitative, objective tools for monitoring disease activity, especially in telemedicine settings, which further compounds challenges for those in remote or underserved areas. Without real-time insights, clinicians face obstacles in making timely, personalized treatment decisions, impacting patient outcomes. This gap underscores an urgent need for innovative solutions to empower patients and clinicians with accurate, actionable disease data